FOLFOX-4 REGIMEN AS ADJUVANT TREATMENT OF RADICALLY RESECATED GASTRIC CANCER PATIENTS

被引：0
|
作者：
Lucia, Cannella [1 ]
Alfonso, De Stefano [1 ]
Antonella, Prudente [1 ]
Carolina, Cimminiello [1 ]
Elide, Matano [1 ]
Roberto, Bianco [1 ]
Chiara, Carlomagno [1 ]
Anna, Crispo [1 ]
Sabino, De Placido [1 ]
机构：
[1] Univ Naples Federico 2, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
    Correale, P
    Fulfaro, F
    Marsili, S
    Cicero, G
    Bajardi, E
    Intrivici, C
    Vuolo, G
    Carli, AF
    Caraglia, M
    Del Prete, S
    Greco, E
    Gebbia, N
    Francini, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (06) : 563 - 568
  • [32] Docetaxel plus FOLFOX4 compared with FOLFOX4 as adjuvant chemotherapy for gastric cancer.
    Du, Chun-Xia
    Liu, Xiao-Yan
    Zhang, Hong-Gang
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [33] Adherence to the FOLFOX4 regimen in colorectal cancer patients
    Gonzalez, J.
    Gonzalez-Navarro, M.
    Albert-Mari, A.
    Lopez-Montenegro, M.
    Romero-Crespo, I.
    Jimenez-Torres, N. V.
    PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1018 - 1018
  • [34] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Axel Grothey
    Nature Clinical Practice Oncology, 2009, 6 : 10 - 11
  • [35] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Grothey, Axel
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (01): : 10 - 11
  • [36] FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer
    Petrioli, Roberto
    Paolelli, Loretta
    Marsili, Stefania
    Civitelli, Serenella
    Francini, Edoardo
    Cioppa, Tommaso
    Roviello, Franco
    Nettuno, Raffaele
    Intrivici, Chiara
    Tanzini, Gabriello
    Lorenzi, Marco
    Francini, Guido
    ONCOLOGY, 2006, 70 (05) : 345 - 350
  • [37] Adjuvant chemotherapy for colon cancer:: Should we simplify the FOLFOX4 regimen?
    Brixi-benmansour, H.
    Bouche, O.
    The, C.
    Burde, F.
    Garcia, B.
    Lagarde, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 38 - 38
  • [38] FOLFOX-4 versus FOLFIRI in the treatment of metastatic colorectal cancer - a prospective randomised study
    Badulescu, F.
    Badulescu, A.
    Schenker, M.
    Ionescu, M.
    Ninulescu, C.
    Crisan, A.
    Dinescu, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 349 - 349
  • [39] Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer
    Liu, Zhi-Fang
    Guo, Qi-Sen
    Zhang, Xi-Qin
    Yang, Xi-Gui
    Guan, Fang
    Fu, Zheng
    Wang, Ming-Yu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (03): : 259 - 263
  • [40] CURE DELAYS AT FOLFOX-4 REGIMEN (A COMBINATION OF LEUKOVORIN AND FLUOROURACIL WITH OXALIPLATIN) IN PATIENTS WITH COLORECTAL CARCINOMA: A RETROSPECTIVE ANALYSIS
    Arpaci, E.
    Yetipyigit, T.
    Ulas, A.
    Paksoy, F.
    Tokluoglu, S.
    Durnali, A.
    Celenkoglu, G.
    Alkis, N.
    ANNALS OF ONCOLOGY, 2010, 21 : 65 - 65
12345